Scholar Rock(SRRK) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Scholar Rock Reports First Quarter 2024 Financial Results and Highlights Business Progress CAMBRIDGE, Mass.--(BUSINESS WIRE)— May 7, 2024-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2024. "Schol ...